Comella Cynthia, Bhatia Kailash
Department of Neurological Sciences, The Movement Disorders Center at Rush University Medical Center, 1725 West Harrison St., Suite 755, Chicago, IL, 60612, USA,
J Neurol. 2015;262(4):837-48. doi: 10.1007/s00415-014-7586-2. Epub 2015 Jan 22.
This was an international survey undertaken to assess cervical dystonia (CD) patients own perceptions of their illness and its management. A total of 1,071 self-identified respondents with CD in 38 countries completed the online survey between March and December 2012. The mean time since diagnosis was 9.6 years and over half (54%) of patients surveyed were not diagnosed in the first year. When asked how the symptoms of CD affected them, two-thirds (66%) of patients reported they experienced a lot of pain, and 61% said that they suffered depression and mood alterations; only 7% reported no impact on their lives. Despite problems with the diagnosis, almost 70% of respondents reported being satisfied with the overall relationship with their doctor. Patient treatment expectations were high, with 63% expecting freedom from spasms and 62% expecting freedom from pain. Over half (53%) expected to be able to return to a normal routine (53%). The most common treatment reported was botulinum toxin (BoNT) (86%), followed by oral medication (58%) and physiotherapy/physical therapy (37%). Among patients treated on BoNT, 56% were fairly/very satisfied, 25% were fairly/very dissatisfied and 20% were neither satisfied nor dissatisfied with the outcome. In conclusion, this international survey highlights the broad impact of CD on several aspects of patient life. Taken overall, the survey suggests that that patients need to be better informed about their condition, treatments available and the limitations of those treatments. It may be that realistically managing patient expectations of treatment would reduce the dissatisfaction of some patients.
这是一项国际调查,旨在评估颈部肌张力障碍(CD)患者对自身疾病及其治疗的看法。2012年3月至12月期间,来自38个国家的1071名自我认定为患有CD的受访者完成了在线调查。自诊断以来的平均时间为9.6年,超过一半(54%)的受访患者在第一年未被诊断出来。当被问及CD症状对他们有何影响时,三分之二(66%)的患者报告称经历了很多疼痛,61%的患者表示患有抑郁症和情绪改变;只有7%的患者报告对他们的生活没有影响。尽管诊断存在问题,但近70%的受访者表示对与医生的总体关系感到满意。患者对治疗的期望很高,63%的患者期望摆脱痉挛,62%的患者期望摆脱疼痛。超过一半(53%)的患者期望能够恢复正常生活。报告的最常见治疗方法是肉毒杆菌毒素(BoNT)(86%),其次是口服药物(58%)和物理治疗(37%)。在接受BoNT治疗的患者中,56%的患者相当/非常满意,25%的患者相当/非常不满意,20%的患者对治疗结果既不满意也不不满意。总之,这项国际调查突出了CD对患者生活多个方面的广泛影响。总体而言,该调查表明,患者需要更好地了解自己的病情、可用的治疗方法以及这些治疗方法的局限性。现实地管理患者对治疗的期望可能会减少一些患者的不满。